In fact, EGFR was part of a cluster of dysregulated genes and enriched gene sets in the FIR20 cells that define the basal breast (cancer) subtype (LAMC2, TRIM29, COL17A and cytokeratin genes (KRT6, KRT7, KRT13, KRT15)) (Data S1). This evidence concerns the gene TRIM29 and cancer.